Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel

MicroRNA-210-3p is the most prominent hypoxia regulated microRNA, and it has been found significantly overexpressed in different human cancers. We performed the expression analysis of miR-210-3p in a retrospective cohort of breast cancer patients with a median follow-up of 76 months (n = 283). An as...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Pasculli, Barbara, Barbano, Raffaela, Rendina, Michelina, Fontana, Andrea, Copetti, Massimiliano, Mazza, Tommaso, Valori, Vanna Maria, Morritti, Maria, Maiello, Evaristo, Graziano, Paolo, Murgo, Roberto, Fazio, Vito Michele, Esteller, Manel, Parrella, Paola
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797767/
https://ncbi.nlm.nih.gov/pubmed/31624308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-51581-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars